How can we minimise the use of regular oral corticosteroids in asthma?
Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Société de Pneumologie de Langue Française workshop on OCSs aimed to conduct a comprehensive revie...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-02-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/29/155/190085.full |